# Kebele Elimination of Trachoma for Ocular Health

> **NCT03335072** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **University of California, San Francisco** · enrollment: 320000 (estimated)

## Conditions studied

- Trachoma

## Interventions

- **DRUG:** Azithromycin

## Key facts

- **NCT ID:** NCT03335072
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-02-07
- **Primary completion:** 2027-03-01
- **Final completion:** 2028-03-01
- **Target enrollment:** 320000 (ESTIMATED)
- **Last updated:** 2025-10-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03335072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03335072, "Kebele Elimination of Trachoma for Ocular Health". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03335072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*